AngioDynamics

AngioDynamics PP&E per Employee

The PP&E per Employee of AngioDynamics (ANGO) as of Sep 21, 2026 is 70,227.85 USD. In the previous year, PP&E per Employee was 71,210.44 USD — a change of -1.38% (lower).

PP&E per Employee

70,227.85USD

YoY

-1.38%

Last updated:

PP&E per Employee of AngioDynamics is 2026 70,227.85 USD. PP&E per Employee of AngioDynamics was 2025 71,210.44 USD. It decreases by -1.38% lower compared to the previous year.

The AngioDynamics PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2016
76,398.73 USD
Jan 1, 2017
71,572.78 USD
Jan 1, 2018
67,185.13 USD
Jan 1, 2019
38,382.91 USD
Jan 1, 2020
44,797.47 USD
Jan 1, 2021
58,659.81 USD
Jan 1, 2022
71,210.44 USD
Jan 1, 2023
70,227.85 USD
The AngioDynamics PP&E per Employee history
YEARPP&E per EmployeeYoY
70,227.85USD-1.38%
71,210.44USD+21.40%
58,659.81USD+30.94%
44,797.47USD+16.71%
38,382.91USD-42.87%
67,185.13USD-6.13%
71,572.78USD-6.32%
76,398.73USD-11.32%
86,155.06USD-18.23%
105,363.92USD
Access this data via the Eulerpool API

AngioDynamics Stock analysis

What does AngioDynamics do? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AngioDynamics stock

PP&E per Employee of AngioDynamics is 70,227.85 USD in 2026.

PP&E per Employee of AngioDynamics changed from 71,210.44 USD to 70,227.85 USD, representing a -1.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee AngioDynamics since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's AngioDynamics historically and in real time.

Access this data via the Eulerpool API

Workforce — AngioDynamics

All Key Metrics — AngioDynamics